Omnigene diagnostics, (OMGD) has a world wide patented process for DNA testing for the detection of periodontal diseases. The company has just signed a contract with Perio-Care Inc.,a nationwide dental center for the non-surgical treatment of periodontitis,a gum disease that effects some 45 million adults in the USA alone. Insurance companies are sure to get involved and demand the use of this test,to prevent un-necessary oral surgery,and reduce the risk of lawsuits to dental professionals.
OMGD's DMD tests have proven 95% accurate in diagnosing bacteria that can cause gum disease. As they have NO COMPETETION,the co. should grow at a fairly rapid pace.Sales lastyear were at $400.000 (96),and projected sales for '97 are over $2,000,000.
There are only 450,000 shares in the float,and most are tightly held,so the board of directors has authorized a 4 for 1 forward split effective mid November.This will increase the amount of shares to be freely traded.As a shareholder,I appreciate the fact that the company is increasing my shares,rather than issuing new shares. It is sort of a bonus for being a shareholder.
The stock price has risen from $1.00 five weeks ago to close at $4.00 on Oct.11th. As more investors become aware of the enormous upside potential of this stock,share prices could soar. You can call the Co. @ 1-800-391-8101 for an information packet. This could be the stock buy of the year. Remember..forward 4 for 1 split mid Nov.
Take a look NOW. Good luck..... John
PS website address is omnigene,com check for news |
